Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1980 Nov;18(6):467-72.
doi: 10.1007/BF00874657.

Comparison of two different loading doses of digoxin in severe renal impairment

Clinical Trial

Comparison of two different loading doses of digoxin in severe renal impairment

E E Ohnhaus et al. Eur J Clin Pharmacol. 1980 Nov.

Abstract

The correct loading dose of digoxin in patients with advanced renal failure is still a matter of discussion. The effects has been studied of loading doses of digoxin 0.625 mg or 1.25 mg given over 48 h according to randomized crossover design to healthy volunteers and to two different groups of patients with renal impairment and the same mean endogenous creatinine clearance of about 15 ml/min. The subsequent maintenance dose for 4 days was digoxin 0.25 mg in the volunteers and 0.125 mg in both groups of patients. The minimum plasma digoxin concentrations before each dose was measured by radioimmunoassay and the plasma levels in the different groups have been compared. In the healthy volunteers no significant difference was found during the study, despite wide variation in the plasma digoxin concentration. In contrast, in patients with renal failure, the group with the higher loading dose showed significantly higher plasma concentrations 24, 36 and 48 h after drug administration, reaching the highest mean value of 2.2 ng/ml at 48 h. However, after 120 h of maintenance therapy a mean digoxin concentration of 1.3 ng/ml was found in both groups. Thus, despite different loading doses identical plasma concentrations were reached during administration of the same maintenance therapy. The higher plasma digoxin concentration obtained during administration of a higher loading dose might be the cause of arrythmias in individual patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Clin Pharmacol. 1979 Mar 26;15(2):115-20 - PubMed
    1. Br Heart J. 1971 Jul;33(4):540-5 - PubMed
    1. Ann Intern Med. 1968 Oct;69(4):703-17 - PubMed
    1. J Pharmacokinet Biopharm. 1975 Jun;3(3):181-92 - PubMed
    1. Clin Nephrol. 1979 Jun;11(6):302-6 - PubMed

LinkOut - more resources